Multi‐Omics Analysis Reveals Photodynamic Therapy Ameliorating Skin Photoaging by Improving Cellular Senescence Through Mitohormesis‐Mediated Reduction of Citrate Content
Aging Cell · 2026-01 · 25 (1)
DOI: 10.1111/acel.70328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 28.12.2025. Verfasst von Yu Yan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Cellular Senescence, Skin Aging, Photochemotherapy, Citric Acid. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality.
Abstract (Originalsprache)
Clinical evidence supports the anti‐photoaging efficacy of 5‐aminolevulinic acid photodynamic therapy (ALA‐PDT), yet its mechanism remains elusive. Paradoxically, ALA‐PDT generates reactive oxygen species (ROS), a key mediator of ultraviolet radiation (UVR)‐induced photoaging, raising questions about its rejuvenating effects. Here, we employed a multi‐omics approach to clarify this paradox. A UVR‐induced hairless mouse model of photoaging was treated with ALA‐PDT, followed by transcriptomic, proteomic, and metabolomic profiling of skin biopsies. In vitro, fibroblast senescence was induced by UV irradiation to evaluate ALA‐PDT's protective effects. Mitochondrial function and citrate (CA) levels were assessed pre‐ and post‐treatment. ALA‐PDT significantly ameliorated photoaging phenotypes in mice, with multi‐omics data revealing sustained improvements in epidermal structure, extracellular matrix integrity, and immune responses. Key mechanistic findings included ALA‐PDT‐induced mitohormesis and tricarboxylic acid cycle reprogramming, notably reduced intracellular CA. In vitro, low‐dose ALA‐PDT downregulated senescence markers and CA content in UV‐stressed fibroblasts, concomitant with upregulated mitohormesis markers. These effects were abrogated by inhibiting mitochondrial ROS, suggesting ROS‐dependent mitohormetic signaling. Collectively, our data demonstrate that low‐dose ALA‐PDT alleviates photoaging by mitigating cellular senescence via mitohormesis‐mediated CA reduction, offering a novel metabolic intervention strategy for age‐related skin disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
ORCID-Profile: Peiru Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Yan, Y., Chang, Q., Wu, Y., Zhao, Y., Yan, G., Cao, Z., Zhang, H., Wang, X., Zeng, Q., & Wang, P. (2026). Multi‐Omics Analysis Reveals Photodynamic Therapy Ameliorating Skin Photoaging by Improving Cellular Senescence Through Mitohormesis‐Mediated Reduction of Citrate Content. Aging Cell, 25(1). https://doi.org/10.1111/acel.70328
Vancouver
Yan Y, Chang Q, Wu Y, Zhao Y, Yan G, Cao Z, et al. Multi‐Omics Analysis Reveals Photodynamic Therapy Ameliorating Skin Photoaging by Improving Cellular Senescence Through Mitohormesis‐Mediated Reduction of Citrate Content. Aging Cell. 2026;25(1). doi:10.1111/acel.70328
BibTeX
@article{Yan2026,
author = {Yan, Yu and Chang, Qihang and Wu, Yun and Zhao, Yiting and Yan, Guorong and Cao, Zhi and Zhang, Haiyan and Wang, Xiuli and Zeng, Qingyu and Wang, Peiru},
title = {Multi‐Omics Analysis Reveals Photodynamic Therapy Ameliorating Skin Photoaging by Improving Cellular Senescence Through Mitohormesis‐Mediated Reduction of Citrate Content},
journal = {Aging Cell},
year = {2026},
volume = {25},
number = {1},
doi = {10.1111/acel.70328}
}
EUVIMED